Great to see the heads of mega banks fulminating against fiction and innuendo as a 'careless talk costs banks' ethos is pounded into their employees and rivals are threatened with retaliation for daring to speculate (ahem) on their illiquidity... a bit like the last season of The Wire, which is looking mighty prophetic in its articulation of the relations between lies, non-reproduction and the (more or less open) collapse of once 'great' institutions.

Signs of Life offers one of the first surveys of the emerging field of ‘bioart’. But, writes Betti Marenko, this book often reveals an art genre in danger of providing biotech with its ultimate PR tool, instead of the critique its production of new economically driven life forms so urgently requires

Nat Muller reviews Sarah Kember's cyberfeminist book

Taking heed of recommendations from the Agriculture and Environment Biotechnology Commission’s report ‘Crops On Trial’, September 2001, the Government launches its national discussion on GM this Spring. Mike Holderness takes a look at the performance so far

Should we play God?" "Is Dolly a monster or a miracle?" ask popular discussions of biotechnology. But what these banal formulations fail to understand is that the current phase of biotech research is characterised by a massive move towards computerisation, with the boundary between wetware and software becoming blurred. Eugene Thacker calls for a more accurate framing of the whole debate